Jonathan Fishbein is an American physician and former director of the National Institutes of Health (NIH) Office for Policy in Clinical Research Operations.
In 2005, Fishbein alleged that an NIH-funded clinical trial of the antiretroviral drug nevirapine, conducted in Africa, was invalid because of poor data collection, faulty record-keeping, and lax quality control.
The clinical trial in question was the HIVNET 012 study, which tested the antiretroviral drug nevirapine, used in some developing countries as a cost-effective method to prevent transmission of HIV from mother to unborn child.
[1] Internal NIH documents showed that concerns had been raised about HIVNET012, but that the Institute did not notify the Bush Administration before the launch of a major project to subsidize nevirapine use in Africa to combat the spread of HIV.
[4] In response to the allegations about nevirapene launched by Fishbein and others, the Institute of Medicine conducted an independent review of HIVNET 012 methodology and findings.